Research at Moorfields Eye Hospital Confirms the Visual Benefits of MacuHealth
Response to supplementation with MacuHealth™ (a formulation consisting of meso-zeaxanthin [10 mg], lutein [10 mg] and zeaxanthin [2 mg]) was conducted by Moorfields Eye Hospital, London. The cohort of 49 subjects included those with non-advanced (n = 12) and advanced (n = 8) age-related macular degeneration, diabetic retinopathy with (n = 10) and without (n = 10) macular edema, central serous chorioretinopathy (n = 5) and no retinal disease (n = 4). By 6 months, statistically significant improvements in glare sensitivity (at low and medium spatial frequencies) were demonstrable, and reflected parallel statistically significant increases in macular pigment, prompting the investigators to conclude that supplementation with MacuHealth™ enhances visual performance and experience in healthy eyes and in eyes with a range of retinal diseases. These favorable observations by Moorfields Eye Hospital regarding the visual benefits of MacuHealth™ in diseased and in non-diseased eyes serve to replicate the findings of other investigators across the world.[2-4]
1. Crosby-Nwaobi, R., et al., An exploratory study evaluating the effects of macular carotenoid supplementation in various retinal diseases. Clin Ophthalmol, 2016. 10: p. 835-44.
2. Ma, L., et al., Lutein, Zeaxanthin and Meso-zeaxanthin Supplementation Associated with Macular Pigment Optical Density. Nutrients, 2016. 8(7).
3. Akuffo, K.O., et al., Sustained supplementation and monitored response with differing carotenoid formulations in early age-related macular degeneration. Eye (Lond). 2015: p. 10.
4. Nolan, J.M., et al., Enrichment of Macular Pigment Enhances Contrast Sensitivity in Subjects Free of Retinal Disease: Central Retinal Enrichment Supplementation Trials - Report 1. Invest Ophthalmol Vis Sci, 2016. 57(7): p. 3429-39.